Can a person with a legal career successfully launch and manage a TV network? Well, Dr. Liaqat Malik | #DrLiaqatMalik, a social entrepreneur with sharp business acumen, creative foresight and extraordinary management abilities has done exactly that and much more.
Humble Beginnings
Born to Pakistani parents who migrated to the UK, Dr. Liaqat Malik | #DrLiaqatMalik never allowed his humble beginnings to stop him from dreaming big. A qualified lawyer http://www.minnesotawildteamstore.com/adidas-ryan-suter-jersey , he used his extensive studies in law to guide and provide legal aid to fellow immigrants. His strong sense of responsibility to the community led him to act as an advisor to organizations specializing in human rights and immigration law among other aspects. Armed with a passion for education, he spent considerable of years as a lecturer and examiner at many UK universities and is now the chairman of an educational establishment.
DM Network
His impressive entrepreneurial portfolio includes successful ventures in the fields of education, social media and communication. Dr. Liaqat Malik | #DrLiaqatMalik founded his television network DM Digital, mainly to cater to the South Asian community. This network has some of the biggest Asian free to air channels and broadcasts programs in a slew of languages including Urdu, Punjabi http://www.minnesotawildteamstore.com/adidas-nino-niederreiter-jersey , Hindi, Kashmiri, Sindhi and English. It has been much appreciated in countries across Europe, Asia, Africa and Oceania where it has garnered dedicated audiences. You can say the network is a perfect blend of entertainment http://www.minnesotawildteamstore.com/adidas-mikko-koivu-jersey , education, religion, live TV and news. It seeks to bridge the gap between South Asian and Western culture, providing comforting succor to audiences across the world. It provides a platform where people from various South Asian ethnic backgrounds can voice their opinions and become a cohesive force.
Entrepreneurial Skills
Dr. Liaqat Malik | #DrLiaqatMalik DM Digital | #DMDigital is an entrepreneur par excellence. He has the uncanny ability to mine the right business opportunities and bring them to a successful conclusion, whilst never losing sight of his commendable desire to serve the community. He takes a keen interest in creating and managing dynamic content for various channels of the network http://www.minnesotawildteamstore.com/adidas-mike-reilly-jersey , ensuring that programs are entertaining and information is useful. His sharing of expertise on criminal law, immigration law and public law on scintillating live discussions has inspired many fellow immigrants in the UK and elsewhere to go after their dreams and create a better life.
In a world where it is getting harder to focus on positive role models, Dr. Liaqat Malik Manchester | #DrliaqatMalikManchester stands out as a beacon of hope and humanism, engaging and inspiring South Asians across the world.
Biopharmaceutical Fermentation Systems Market to Reach US$ 17.8 Bn by 2026
by Metcarl · December 6, 2018
The global biopharmaceutical fermentation systems market was valued at around US$ 10.0 Bn in 2017 and is anticipated to expand at a CAGR of more than 6.0% from 2018 to 2026 to reach a value of around US$ 17.8 Bn in 2026. Emphasis on the development and marketing of innovative products and solutions such as single-use systems and continuous bioprocessing is likely to drive the biopharmaceutical fermentation systems market market. Moreover http://www.minnesotawildteamstore.com/adidas-mikael-granlund-jersey , expansion by key players in emerging markets through contracts and collaborations is anticipated to propel the market in the coming years. For instance, expansion in Asia Pacific through flexible and modular manufacturing facility solutions and collaboration with biopharmaceutical manufacturers to develop and improve bioprocess products.
Read Report Overview:
In terms of application, the recombinant proteins segment held a major market share in 2017. High reliance on microbial systems for recombinant protein production contributed toward the leading share of the segment. Increase in investment in research activities and introduction of new protein therapeutics have significantly contributed to the development of recombinant therapeutic antibodies and proteins. Moreover, rise in the number of clinical trials in the pharmaceutical industry have boosted the segment in past few years. The recombinant proteins segment is expected to dominate the market during the forecast period, owing to an increased focus on developing innovative fusion protein and antibody-drug conjugates products.
Based on end-user http://www.minnesotawildteamstore.com/adidas-matt-dumba-jersey , the biopharmaceutical companies segment accounted for a major market share in 2017. Well-equipped infrastructure and strong expertise have led to the dominant share of the segment. Biopharmaceutical companies such as Shire plc, AstraZeneca, Pfizer, Johnson & Johnson, GlaxoSmithKline [url=http://www.minnesotawildteamstore.com/adidas-matt-cullen-jersey]http://www.minnesotawildte
German Drift Crew
Thema drucken
17.07.2019 04:05
Antworten
